ADA 2020: A Bayesian Narrative of Glycaemic Control on MACE

Published: 10 Jul 2020

  • Views:

    Views Icon 175
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Dr Shao Hui (University of Florida, Florida, US) discusses the rationale and methods behind a Bayesian interpretation on whether intensive glycaemic control can reduce major adverse cardiovascular events (MACE) using data in long-term clinical trials (e.g. ACCORD and VADT). 


1. What is the rationale behind this analysis?
2. What were the methods of this analysis?
3. What were your findings?
4. What conclusions can be made?

Filmed remotely from Florida, 2020.

Interviewer: Victoria Perroud
Recording Editor: Natascha Wienand